I watched the SBS broadcast and commend them on an informative...

I watched the SBS broadcast and commend them on an informative well balanced coverage. While it may not ignite the SP, it has definitely focused very positive attention on this sector. It covered Australian legislative issues and lack of clinical trials but also focused on the Israeli connection where trials have been documented since the 1960's. I must stress we have Israeli board members and Sydney University connections on our board, so it would seem MXC is very well positioned to capitalize on this growth industry. Great result really, lets see what transpires.